New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Illumina, Inc.
ILMN
Shape
US Flag

NASDAQ

23B

Medical - Diagnostics & Research

Next Earning date - 04 Nov 2024

23B

Medical - Diagnostics & Research

Next Earning date - 04 Nov 2024

141.95USD
Shape0.56 ( 0.40%)
favorite-chart

Relative Strenght

11
favorite-chart

Volume Buzz

-44%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

6%

Quote Panel

Shape
Updated October 27, 2024
1W -2.25 % 1M 8.85 % 3M 16.77 % 1Y 35.41 %

Key Metrics

Shape
  • Market Cap

    22.61B


  • Shares Outstanding

    159.30M


  • Share in Float

    158.48M


  • Dividende

    0


  • Earning Date

    04 Nov 2024


  • Price Target

    141.95


  • Average Volume

    1.72M


  • Beta

    1.147


  • Range

    86.575874-151.4


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.illumina.com


  • Sector

    Healthcare


Fundamentals

Shape

154.29x

P/E Ratio

5.11x

P/S Ratio

15.72x

P/B Ratio

1.6

Debt/Equity

-68.7%

Net Margin

$-19.2

EPS

How ILMN compares to sector?

P/E Ratio

Relative Strength

Shape

ILMN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5B

Shape310%

2025-Revenue

$3.69

Shape130%

2025-EPS

$1B

Shape134%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

HSBC

upgrade

Previous: Not converted

2024-10-17

Now: Buy

Daiwa

upgrade

Previous: Not converted

2024-08-16

Now: Buy

Wedbush

upgrade

Previous: Neutral

2024-08-14

Now: Outperform

Goldman Sachs

upgrade

Previous: Not converted

2024-08-14

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-77%

0.34
vs 1.45

Q1.23

arrow
arrow

-81%

0.14
vs 0.75

Q2.23

arrow
arrow

-93%

0.08
vs 1.07

Q3.23

arrow
arrow

-44%

0.32
vs 0.57

Q4.23

arrow
arrow

-3%

0.33
vs 0.34

Q4.23

arrow
arrow

-59%

0.14
vs 0.34

Q1.24

arrow
arrow

-36%

0.09
vs 0.14

Q2.24

arrow
arrow

+350%

0.36
vs 0.08

Q3.24

arrow
arrow

+175%

0.88
vs 0.32

Q4.24

arrow
arrow

+580%

0.95
vs 0.14

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+1%

1.1B  vs 1.1B

Q1.23

arrow
arrow

-10%

1.1B  vs 1.2B

Q2.23

arrow
arrow

-11%

1.1B  vs 1.2B

Q3.23

arrow
arrow

+1%

1.2B  vs 1.2B

Q4.23

arrow
arrow

+0%

1.1B  vs 1.1B

Q4.23

arrow
arrow

+1%

1.1B  vs 1.1B

Q1.24

arrow
arrow

-1%

1.1B  vs 1.1B

Q2.24

arrow
arrow

+2%

1.1B  vs 1.1B

Q3.24

arrow
arrow

-8%

1.1B  vs 1.2B

Q4.24

arrow
arrow

-1%

1.1B  vs 1.1B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-57%

-0.57
vs -0.05

Q1.23

arrow
arrow

-2%

-0.02
vs -0.57

Q2.23

arrow
arrow

+0%

0
vs -0.02

Q3.23

arrow
arrow

-4%

-0.04
vs 0

Q4.23

arrow
arrow

-13%

-0.13
vs -0.04

Q4.23

arrow
arrow

-3%

-0.03
vs -0.13

Q1.24

arrow
arrow

-2%

-0.02
vs -0.03

Q2.24

arrow
arrow

-138%

-1.38
vs -0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

942

942
vs 938

0%

Q4.22

arrow
arrow

983

983
vs 942

4%

Q1.23

arrow
arrow

973

973
vs 983

-1%

Q2.23

arrow
arrow

922

922
vs 973

-5%

Q3.23

arrow
arrow

848

848
vs 922

-8%

Q4.23

arrow
arrow

846

846
vs 848

0%

Q1.24

arrow
arrow

819

819
vs 846

-3%

Q2.24

arrow
arrow

774

774
vs 819

-5%

Earnings Growth

Latest News